Klaria Pharma Holding AB TEMP's next confirmed earnings release is scheduled for November 26, 2026.
| Earnings Date | 11/26/2026 |
As of June 30, 2026, Klaria Pharma Holding AB TEMP has 64.99M shares outstanding.
| Shares Outstanding | 64.99M |
As of June 30, 2026, Klaria Pharma Holding AB TEMP maintains a current ratio of 0.20, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.20 |
| Quick Ratio | 0.14 |
These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -88.24, reflecting losses generated across the asset base. The company generates approximately 38,250.00 in revenue per employee across its workforce of 4.00, a quick read on workforce productivity versus industry peers.
| Return on Assets (ROA) | -88.24 |
| Revenue Per Employee | 38,250.00 |
| Employee Count | 4.00 |
Over the twelve months ended June 30, 2026, Klaria Pharma Holding AB TEMP generated 153,000.00 in revenue and converted that into -38.72M in net income, yielding earnings per share of -0.61. EBITDA reached -23.18M, while operating income came in at -31.61M.
| Revenue | 153,000.00 |
| Operating Income | -31.61M |
| Pretax Income | -38.72M |
| Net Income | -38.72M |
| EBITDA | -23.18M |
| EBIT | -31.61M |
| Earnings Per Share (EPS) | -0.61 |
These figures are as of June 30, 2026. Total book value stands at -33.61M, with working capital of -48.82M providing operational flexibility.
| Cash & Cash Equivalents | 8.47M |
| Net Debt | -8.47M |
| Equity (Book Value) | -33.61M |
| Book Value Per Share | -0.52 |
| Working Capital | -48.82M |
Klaria Pharma Holding AB TEMP produced -48.51M in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -48.51M - equivalent to -0.77 per share.
| Operating Cash Flow | -48.51M |
| Free Cash Flow | -48.51M |
| FCF Per Share | -0.77 |
These figures cover the twelve months ended June 30, 2026. The operating margin of -20,660.13 and net profit margin of -25,306.54 provide insight into operational efficiency.
| Operating Margin | -20,660.13 |
| Pretax Margin | -25,306.54 |
| Profit Margin | -25,306.54 |
| EBITDA Margin | -15,148.37 |
Already premium?